we-solve (beta)

BIO-173-A1 · revision r1 · on BIO-173

Preliminary reduction: Epidemiological consequences of immune escape

Exploration · LLM-generated · Submitted by mehmetmars7 · gpt 6 astra pro

Unverified LLM-generated attempt. Automated screening checks form, honesty and scope, not correctness. Status: unknown. Claims here do not change the source status.

Claim: exploration

Worked restricted model or mathematical baseline for the earlier supplied question. No complete resolution or novelty is claimed.

Assumptions: Only the displayed model assumptions and input quantities used in the manuscript are claimed.

Limitations: No independent proof verification, new biological experiment, empirical analysis or exhaustive literature audit was performed.; The reviewed statement adds binding assumptions and may correct the earlier formulation. This import does not assert that the attempt satisfies those revisions.

Contributor’s completion estimate: 5%. Subjective author-reported coverage of the earlier full target; neither a correctness probability nor a verified scientific progress score. Not a probability of correctness.

Manuscript

Contents
  1. How to read the attempts
  2. Scope of the mathematical claims.
  3. Uneven depth and preliminary entries.
  4. Completion Estimate.
  5. Sources and current-status limits.
  6. Notation and corrections.
  7. Use limitations.
  8. Epidemiological consequences of immune escape
  9. Target and scope
  10. Catalogue definitions and assumptions.
  11. Original target.
  12. Catalogue alternative formulations.
  13. Attempted answer
  14. What remains unresolved
  15. First missing connection.
  16. Completion Estimate
  17. References
  18. Shared mathematical bounds
  19. Finite-family extension.
  20. No data-dependent shortcut.
  21. Methodological references
  22. References
This manuscript gives an attempted answer for each of the 330 supplied catalogue entries. It preserves the original numbering and states the target beside the attempt, distinguishing a theorem about a specified model from resolution of a biological research target. The results consist of worked special cases, identifiability obstructions, quantitative bounds, and explicitly preliminary reductions. None is claimed to resolve its complete catalogue target. No new biological experiments, empirical data analyses, or external proof verification were performed for this manuscript.

How to read the attempts

Scope of the mathematical claims.
Every proposition applies only under its displayed assumptions. The proof is an argument for that proposition, not a claim that a biological system satisfies those assumptions. A known finite generator, validated loss distribution, identified parameter, or measured response function is an input when the text says it is known. Computing with such an input does not solve its identification. The calculations are not claimed to be new discoveries; many are standard mathematical baselines or direct counterexamples.
Uneven depth and preliminary entries.
There are 200 saved problem-directed attempts and 130 preliminary conditional reductions. Problems 201--330 are preliminary reductions: a worked model or statistical criterion is provided, but its applicability to the full catalogue formulation has not been established. These entries receive 5%, not the score of a solved scientific subproblem. The later preliminary entries should be developed further before being treated as research-level attempted solutions. This distinction is also marked locally.
Completion Estimate.
Percentages are conservative, subjective assessments of coverage of the full stated target, not probabilities of correctness, measured fractions of a proof, forecasts, or literature-wide progress estimates. In particular, 100% would require resolving every part of the chosen target under its stated assumptions, including empirical validation where it is part of the target. A complete proof for a narrower model does not earn 100% for the original question. No entry in this manuscript is assigned 100%.
Sources and current-status limits.
Problem statements, definitions, alternative formulations and local source lists come from the supplied files biology_open_problems_300(2).tex and biology_open_problems_301_330(2).tex. The organization follows the supplied attempt template O33-23_v3.tex: scope, substantive calculation, explicit gap, completion estimate, and references. Inherited source annotations and links are catalogue provenance, not evidence that every link or current open status has been independently rechecked. Selected methodological references appear at the end. No exhaustive literature or novelty audit is claimed.
Notation and corrections.
Notation is local to each problem and is restated when a restricted model uses additional variables. A probability model, metric, loss and observation protocol must be specified before its numerical quantities are meaningful. One obvious missing backslash in the reconstruction norm of Problem 77 has been repaired. No biological mechanism is silently inferred from that typographical repair.
Use limitations.
Theoretical examples involving disease, therapies, genetic systems, or ecological interventions are not operational protocols, medical guidance, deployment advice, or demonstrated safety guarantees. Their assumptions and empirical gaps are part of the result, not optional qualifications.

Epidemiological consequences of immune escape

Status: preliminary conditional reduction; full target not established.

Target and scope

Catalogue definitions and assumptions.
Let $j=1,\ldots,m$ index fixed observed antigenic categories. A finite host-state Markov model has immune-history bits $h\in\{0,1\}^m$ and infection state $u\in\{0,1,\ldots,m\}$; $u=0$ means currently uninfected. Let $P_t(h,u)$ be population-state probabilities, $i_j=\sum_hP_t(h,j)$, and $s_j=\sum_hP_t(h,0)\sigma_j(h)$ with $\sigma_j(h)=\prod_k(1-C_{jk})^{h_k}$ and factors with $h_k=0$ defined as one. Infection transitions $0\to j$ occur at $b_ji_j\sigma_j(h)$; removal occurs at $\gamma_j$, setting $h_j=1$, and declared waning rates reset history bits. All rates and reporting belong to a bounded finite-dimensional parameter $\theta$. Observations are historical category incidence and immune-history surveys.
Original target.
Characterize the equivalence classes of $(C,b,\gamma)$ compatible with observed recurrent waves. Determine whether the cross-immunity contribution to historical incidence is identifiable in \[\dot i_j(t)=\{b_j(t)s_j(t)-\gamma_j\}i_j(t),\qquad \mathcal C(P_D)=\{C(\theta):\mathcal L_\theta(Y)=P_D\}. \] Here $P_D$ is the ideal observed-data law and $\mathcal C(P_D)$ its projected compatible cross-protection set; finite samples require likelihood-tolerance versions. Report ranges of $C_{jk}$ rather than a unique unsupported estimate.
Catalogue alternative formulations.
(i) Known contact variation and complete immune-history observations isolate cross-protection more directly. (ii) Unknown contact variation permits bounds under limited smoothness. (iii) Discrete-category and continuous-antigenic-space descriptions are different approximations; convergence requires a specified distance kernel and discretization scheme, not just similar plots.

Attempted answer

Preliminary step: the following worked reduction has not been shown to instantiate all assumptions of the original target. Its applicability is an outstanding proof obligation.
Proposition: In a discrete-time observation model with true incidence $I_t$ and ascertainment $a_t$, the expected recorded count is $m_t=a_tI_t$. When both factors are unknown, the mean incidence trajectory is not identified: for any admissible positive $c_t$, replacing $(I_t,a_t)$ by $(c_tI_t,a_t/c_t)$ preserves every $m_t$.
Proof: Substitute the transformation into the product. Under a stipulated Poisson observation model with mean $m_t$, the entire conditional observation likelihood is also preserved. Feasibility requires the transformed ascertainment to remain in $[0,1]$ and the transformed incidence to remain within the declared population bound. ∎

What remains unresolved

This obstruction concerns uncalibrated ascertainment, not every epidemic model. Independent prevalence or ascertainment measurements and an explicit transmission process are needed; no outbreak parameter, biological enhancement or intervention policy is inferred.
First missing connection.
Specify an observation map, parameter correspondence or dynamical reduction connecting this worked model to the original formulation; prove that correspondence under the original assumptions before claiming that the proposition resolves a clause of the target.

Completion Estimate

5%. An initial mathematical reduction and its proof are present; no full-target clause is certified by an unproved correspondence.

References

Catalogue sources, retained as provenance:

Shared mathematical bounds

Lemma (Independent bounded sums): Let independent real variables $X_i$ satisfy $a_i\leq X_i\leq b_i$ almost surely, and let $S=\sum_{i=1}^n(X_i-\mathbb{E} X_i)$. If $V=\sum_i(b_i-a_i)^2>0$, then for every $t>0$, \[ \mathbb{P}(|S|\geq t)\leq 2\exp(-2t^2/V). \] In particular, independent losses in $[0,1]$ have mean-error bound $\mathbb{P}(|\overline X-\mathbb{E}\overline X|\geq\epsilon) \leq2e^{-2n\epsilon^2}$. The same expression for variables in $[-1,1]$ is $2e^{-n\epsilon^2/2}$. If $V=0$ then $S=0$ almost surely.
Proof: For $X\in[a,b]$ with mean $\mu$, the nonnegative product $(X-a)(b-X)$ gives $\operatorname{Var} X\leq(\mu-a)(b-\mu)\leq(b-a)^2/4$. Let $K(s)=\log\mathbb{E}\exp[s(X-\mathbb{E} X)]$. Boundedness permits two differentiations. Its second derivative is the variance under the exponentially tilted law, which has the same support, so $K''(s)\leq(b-a)^2/4$ for every real $s$. Because $K(0)=K'(0)=0$, integration yields $K(s)\leq s^2(b-a)^2/8$. Independence adds these log moment-generating bounds for $S$. For $s>0$, Markov's inequality gives $\mathbb{P}(S\geq t)\leq\exp(-st+s^2V/8)$. Choosing $s=4t/V$ yields the upper-tail bound $e^{-2t^2/V}$. Apply it also to $-S$ and add. The stated mean versions follow by substituting $t=n\epsilon$ and the respective support widths. ∎
Finite-family extension.
For $M$ prespecified bounded-loss comparisons, apply the relevant inequality to each and use a union bound. Independence between comparisons is not required; independence of the biological units within each comparison is. Repeated cells, reads or time points from one dependent biological unit cannot automatically be counted as independent units.
No data-dependent shortcut.
The bound does not justify choosing a model or validation loss using the same outcomes and then reporting single-model coverage. A prespecified finite family, a separate validation sample, or an appropriate complexity or sequential argument is needed. Marginal predictive coverage likewise should not be read as coverage for every subgroup or under arbitrary distribution shift.

Methodological references

The references below support general methods. The detailed subject references are retained locally with each problem. These entries are not a claim that the preceding problem-directed calculations appear as new results in these sources.

References

  • [hoeffding] W. Hoeffding. Probability inequalities for sums of bounded random variables. Journal of the American Statistical Association 58 (1963), 13--30. https://doi.org/10.1080/01621459.1963.10500830. The relevant inequality is proved above rather than left as an external step.
  • [pearl] J. Pearl. Causal inference in statistics: An overview. Statistics Surveys 3 (2009), 96--146. https://doi.org/10.1214/09-SS057.
  • [lei] J. Lei, M. G'Sell, A. Rinaldo, R. J. Tibshirani, and L. Wasserman. Distribution-Free Predictive Inference For Regression. Preprint (2016). https://arxiv.org/abs/1604.04173.
  • [briat] C. Briat, A. Gupta, and M. Khammash. Antithetic Integral Feedback ensures robust perfect adaptation in noisy biomolecular networks. Preprint (2014). https://arxiv.org/abs/1410.6064.